Skip to Content

Nobivac Canine 1-Pv

This page contains information on Nobivac Canine 1-Pv for veterinary use.
The information provided typically includes the following:
  • Nobivac Canine 1-Pv Indications
  • Warnings and cautions for Nobivac Canine 1-Pv
  • Direction and dosage information for Nobivac Canine 1-Pv

Nobivac Canine 1-Pv

This treatment applies to the following species:
Company: Intervet/Merck Animal Health

PARVOVIRUS VACCINE

Modified Live Virus

FOR ANIMAL USE ONLY

IN THE ABSENCE OF A VETERINARIAN-CLIENT-PATIENT RELATIONSHIP, FEDERAL REGULATIONS PROHIBIT THE RELABELING, REPACKAGING, RESALE OR REDISTRIBUTION

OF THE INDIVIDUAL CONTENTS OF THIS PACKAGE.

Nobivac Canine 1-Pv Indications

This product has been shown to be effective for vaccination of healthy dogs 6 weeks of age or older against canine parvovirus. Duration of Immunity has not been established. To review efficacy and safety data, go to productdata.aphis.usda.gov.

Dosage and Administration

Inject one dose (1mL) subcutaneously or intramuscularly. The initial dose may be given at 6 weeks of age or older. Repeat dose 2 to 4 weeks later. Two doses are required for primary immunization.

The presence of maternal antibodies is known to interfere with the development of active immunity in dogs and additional boosters will be required in most young animals. Historically, annual revaccination has been recommended for this product. The need for this booster has not been established. For more information on revaccination frequency, in general or in the face of maternal antibody, consult your veterinarian or the manufacturer.

Precautions

● Store at 2° - 8°C (35°-46°F).

● Do not freeze.

● Use new, non-chemically sterilized needles and syringes.

● Do not mix with other products.

● Inactivate unused contents before disposal.

● In case of human exposure, contact a physician.

Warnings

● Contains gentamicin and thimerosal as preservatives.

● Vaccinate only healthy, non-parasitized dogs.

● Do not vaccinate pregnant bitches.

● The use of a biological product may produce anaphylaxis and or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.

● The age at which maternal antibody for canine parvovirus no longer interferes with the development of active immunity varies according to the bitch’s titer and quantity of colostral antibodies absorbed by the puppy.

Intervet Inc. d/b/a Merck Animal Health

Omaha, NE 68103 USA

VLN 165A/PCN 18M1.20

1 800 224-5318 (USA)

1 866 683-7838 (Canada)

For patent information:

http://www.merck.com/product/patent/home.html

 

Code

 

25x1 DOSE

065300

322881-03

CPN: 1047087.7

MERCK ANIMAL HEALTH
Intervet Inc.

2 GIRALDA FARMS, MADISON, NJ, 07940
Customer Service:   800-521-5767
Order Desk:   800-648-2118
Technical Service (Companion Animal):   800-224-5318
Technical Service (Livestock):   800-211-3573
Fax:   973-937-5557
Website:   www.merck-animal-health-usa.com
Every effort has been made to ensure the accuracy of the Nobivac Canine 1-Pv information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2020 Animalytix LLC. Updated: 2020-10-21